Journal Information
Vol. 92. Issue 5.
Pages 540-541 (September - October 2016)
Vol. 92. Issue 5.
Pages 540-541 (September - October 2016)
Letter to the Editor
Open Access
Authors’ reply: Atypical manifestations of Epstein–Barr virus: red alert for primary immunodeficiencies
Resposta dos autores: manifestações atípicas do vírus de Epstein-Barr: alerta vermelho para imunodeficiências primárias
Visits
2643
Vasileios Bolisa,
Corresponding author
v.bolis7@gmail.com

Corresponding author.
, Christos Karadedosa, Ioannis Chiotisa, Nikolaos Chaliasosb, Sophia Tsabourib
a University Hospital of Ioannina, Ioannina, Greece
b University Hospital of Ioannina, Child Health Department, Ioannina, Greece
Related content
J Pediatr (Rio J). 2016;92:539-4010.1016/j.jped.2016.05.002
Gesmar R.S. Segundo
This item has received

Under a Creative Commons license
Article information
Full Text
Bibliography
Download PDF
Statistics
Full Text
Dear Editor,

Human primary immunodeficiency disease (PID) is a condition where mutations in single immune system genes predispose individuals to certain infectious agents. The human herpesviruses are a challenge of immune competence, since most of these agents are widespread in the population; they are often acquired silently or with mild symptoms in childhood and then carried for life as asymptomatic latent infections. PID patients are therefore likely to be exposed to these viruses relatively early in life and will have to deal with them both as a primary infection and as a persistent condition.1 For individuals who are immunocompromised, due to a genetic immunodeficiency or immunosuppressive drug therapy, viral infections may result in severe complications and even life-threatening disease.2

PID is considered a rare disease, with an overall incidence of 4.6 cases of PIDs per 100,000 person-years in the last 35 years.3 However, neither the true incidence nor the true prevalence of PID are known. Although there have been estimates of these parameters from geographically limited studies, those estimates were based only on diagnosed cases. Therefore, PID may be far more common than previously estimated. Surveys suggest prevalence rates for diagnosed PID as 1:2000 for children, 1:1200 for all persons, and 1:600 households.4

Specific gene mutations in PID patients are responsible for susceptibility to Epstein–Barr virus (EBV) infections, as highlighted in the letter to the editor of the Jornal de Pediatria entitled “Atypical manifestations of Epstein–Barr virus: red alert for primary immunodeficiencies”. Although PID and atypical complications of EBV infection are not very common, pediatricians should indeed correlate these two conditions as mentioned in the previous letter, since EBV infects more than 95% of the adult population worldwide.5 PID incidence has increased in the last decades,3 and patients with immunodeficiency are the group most exposed to atypical complications of EBV among healthy people.

The strongest predictor of PID is family history. Moreover, when an immunodeficiency disease is suspected, initial laboratory screening should include a complete blood count with differential and measurement of serum immunoglobulin and complement levels.6

Conflicts of interest

The authors declare no conflicts of interest.

References
[1]
U. Palendira, A.B. Rickinson.
Primary immunodeficiencies and the control of Epstein–Barr virus infection.
Ann N Y Acad Sci, 1356 (2015), pp. 22-44
[2]
L.K. Dropulic, J.I. Cohen.
Severe viral infections and primary immunodeficiencies.
Clin Infect Dis, 53 (2011), pp. 897-909
[3]
A.Y. Joshi, V.N. Iyer, J.B. Hagan, J.L. St Sauver, T.G. Boyce.
Incidence and temporal trends of primary immunodeficiency: a population-based cohort study.
Mayo Clin Proc, 84 (2009), pp. 16-22
[4]
J.M. Boyle, R.H. Buckley.
Population prevalence of diagnosed primary immunodeficiency diseases in the United States.
J Clin Immunol, 27 (2007), pp. 497-502
[5]
N. Parvaneh, A.H. Filipovich, A. Borkhardt.
Primary immunodeficiencies predisposed to Epstein–Barr virus-driven haematological diseases.
Br J Haematol, 162 (2013), pp. 573-586
[6]
C.E. Reust.
Evaluation of primary immunodeficiency disease in children.
Am Fam Physician, 87 (2013), pp. 773-778

Please cite this article as: Bolis V, Karadedos C, Chiotis I, Chaliasos N, Tsabouri S. Authors’ reply: Atypical manifestations of Epstein–Barr virus: red alert for primary immunodeficiencies. J Pediatr (Rio J). 2016;92:540–1.

Copyright © 2016. Sociedade Brasileira de Pediatria
Download PDF
Idiomas
Jornal de Pediatria (English Edition)
Article options
Tools
en pt
Taxa de publicaçao Publication fee
Os artigos submetidos a partir de 1º de setembro de 2018, que forem aceitos para publicação no Jornal de Pediatria, estarão sujeitos a uma taxa para que tenham sua publicação garantida. O artigo aceito somente será publicado após a comprovação do pagamento da taxa de publicação. Ao submeterem o manuscrito a este jornal, os autores concordam com esses termos. A submissão dos manuscritos continua gratuita. Para mais informações, contate assessoria@jped.com.br. Articles submitted as of September 1, 2018, which are accepted for publication in the Jornal de Pediatria, will be subject to a fee to have their publication guaranteed. The accepted article will only be published after proof of the publication fee payment. By submitting the manuscript to this journal, the authors agree to these terms. Manuscript submission remains free of charge. For more information, contact assessoria@jped.com.br.
Cookies policy Política de cookies
To improve our services and products, we use "cookies" (own or third parties authorized) to show advertising related to client preferences through the analyses of navigation customer behavior. Continuing navigation will be considered as acceptance of this use. You can change the settings or obtain more information by clicking here. Utilizamos cookies próprios e de terceiros para melhorar nossos serviços e mostrar publicidade relacionada às suas preferências, analisando seus hábitos de navegação. Se continuar a navegar, consideramos que aceita o seu uso. Você pode alterar a configuração ou obter mais informações aqui.